Related Experiment Videos
Multidisciplinary interventions: mapping new horizons in diabetes care
Edward Horton1, William T Cefalu, Stuart T Haines
1Vice President and Director of Clinical Research, Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA. Edward.Horton@joslin.harvard.edu
The Diabetes Educator
|September 20, 2008
Summary
Emerging incretin therapies offer new hope for managing type 2 diabetes by improving glucose control and addressing alpha-cell and beta-cell dysfunction. These treatments, including fixed-dose combinations, may enhance patient adherence and reduce costs.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Diabetes mellitus affects over 20 million Americans, with obesity as a key driver.
- Current treatments for type 2 diabetes mellitus target insulin resistance and pancreatic islet dysfunction.
- Existing therapies do not fully address alpha-cell and beta-cell dysfunction.
Purpose of the Study:
- To review the role of incretin augmentation therapies in managing type 2 diabetes.
- To highlight the advantages of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase IV inhibitors.
- To discuss the benefits of fixed-dose combinations for patient adherence and cost reduction.
Main Methods:
- Review of current literature on incretin-based therapies for type 2 diabetes.
- Analysis of clinical trial data on glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase IV inhibitors.
- Evaluation of patient-reported outcomes and adherence factors for combination therapies.
Main Results:
- Incretin therapies effectively address alpha-cell and beta-cell dysfunction, restoring glucose homeostasis.
- These agents are associated with a low incidence of hypoglycemia and no weight gain.
- Fixed-dose combinations of dipeptidyl peptidase IV inhibitors improve adherence and reduce patient burden.
Conclusions:
- Incretin augmentation therapies represent a significant advancement in type 2 diabetes management.
- Combination regimens offer a promising strategy to improve patient outcomes and adherence.
- Patient education on treatment benefits, costs, and complexity is crucial for successful implementation.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:21Interdisciplinary Care: The Health Care Team-I
An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution itself.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution itself.
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...